Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03229278
Title Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rutgers, The State University of New Jersey

Advanced Solid Tumor



Nivolumab + Pembrolizumab + Trigriluzole

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.